The first clinically-relevant mouse model of human breast cancer to successfully express functional estrogen receptor positive adenocarcinomas has been created by researchers. This model should be a powerful tool for testing therapies for aggressive ER+ breast cancers and for studying luminal cancers -- the most prevalent and deadliest forms of breast cancer.
The first clinically-relevant mouse model of human breast cancer to successfully express functional estrogen receptor positive adenocarcinomas has been created by researchers. This model should be a powerful tool for testing therapies for aggressive ER+ breast cancers and for studying luminal cancers -- the most prevalent and deadliest forms of breast cancer.
Share this Article
Recommended